Logo image of BLU.CA

BLUENERGIES LTD (BLU.CA) Stock Price, Quote, News and Overview

TSX:BLU - Toronto Stock Exchange - CA0959221007 - Common Stock - Currency: CAD

0.47  +0.02 (+4.44%)

BLU.CA Quote, Performance and Key Statistics

BLUENERGIES LTD

TSX:BLU (6/18/2025, 7:00:00 PM)

0.47

+0.02 (+4.44%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap59.60M
Shares126.80M
Float104.23M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)02-24 2022-02-24
IPO06-22 2000-06-22


BLU.CA short term performance overview.The bars show the price performance of BLU.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 1 2 3 4

BLU.CA long term performance overview.The bars show the price performance of BLU.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of BLU.CA is 0.47 CAD.

BLUENERGIES LTD / BLU Daily stock chart

BLU.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRX.CA FENNEC PHARMACEUTICALS INC N/A 297.47M
EDT.CA SPECTRAL MEDICAL INC N/A 248.05M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 216.18M
TH.CA THERATECHNOLOGIES INC N/A 157.71M
ONC.CA ONCOLYTICS BIOTECH INC N/A 85.27M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 68.05M
COV.CA COVALON TECHNOLOGIES LTD 18.54 66.08M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 55.19M
HBP.CA HELIX BIOPHARMA CORP N/A 47.72M
MBX.CA MICROBIX BIOSYSTEMS INC 30 42.24M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 41.96M
BCT.CA BRIACELL THERAPEUTICS CORP N/A 25.77M

About BLU.CA

Company Profile

BLU logo image BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. The company is headquartered in Laval, Quebec and currently employs 74 full-time employees. The company went IPO on 2000-06-22. The firm's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The firm has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The firm is focused on initiating Phase III program. The firm is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.

Company Info

BLUENERGIES LTD

275 Armand-Frappier Blvd

Laval QUEBEC H7V 4A7 CA

CEO: Roberto Bellini

Employees: 74

BLU Company Website

BLU Investor Relations

Phone: 14506804500.0

BLUENERGIES LTD / BLU.CA FAQ

What is the stock price of BLUENERGIES LTD today?

The current stock price of BLU.CA is 0.47 CAD. The price increased by 4.44% in the last trading session.


What is the ticker symbol for BLUENERGIES LTD stock?

The exchange symbol of BLUENERGIES LTD is BLU and it is listed on the Toronto Stock Exchange exchange.


On which exchange is BLU.CA stock listed?

BLU.CA stock is listed on the Toronto Stock Exchange exchange.


What is BLUENERGIES LTD worth?

BLUENERGIES LTD (BLU.CA) has a market capitalization of 59.60M CAD. This makes BLU.CA a Micro Cap stock.


How many employees does BLUENERGIES LTD have?

BLUENERGIES LTD (BLU.CA) currently has 74 employees.


What are the support and resistance levels for BLUENERGIES LTD (BLU.CA) stock?

BLUENERGIES LTD (BLU.CA) has a support level at 0.44 and a resistance level at 0.48. Check the full technical report for a detailed analysis of BLU.CA support and resistance levels.


Should I buy BLUENERGIES LTD (BLU.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BLUENERGIES LTD (BLU.CA) stock pay dividends?

BLU.CA does not pay a dividend.


When does BLUENERGIES LTD (BLU.CA) report earnings?

BLUENERGIES LTD (BLU.CA) will report earnings on 2022-02-24.


BLU.CA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to BLU.CA.


Chartmill TA Rating
Chartmill Setup Rating

BLU.CA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

BLU.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to BLU.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts76
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A